It is a sign of the trust that the dermatology community has in EndyMed’s 3DEEP® technology that so many doctors from different countries had their scientific papers accepted by WCD
Caesarea, Israel (PRWEB) June 09, 2015
EndyMed Medical, a world leader in non-invasive, medical aesthetic treatment solutions for facial and body skin improvement, announced that it would be presenting four posters at the Word Congress of Dermatology in Canada. Written by well-respected medical practitioners from around the world, these posters further prove that EndyMed’s FDA approved 3DEEP® radiofrequency technology delivers a superior, cutting edge solution for non-invasive wrinkle reduction, skin tightening, fractional skin resurfacing and RF microneedling for both the face and body, body contouring and acne scar treatment.
The World Congress of Dermatology is an important event for the Dermatology world, bringing together medical, surgical, and esthetic dermatology professionals every 4 years. “It is a sign of the trust that the dermatology community has in EndyMed’s 3DEEP® technology that so many doctors from different countries had their scientific papers accepted by WCD," said internationally renowned, Board Certified Dermatologist, Dr. Yoram Harth, Co-Founder of EndyMed Medical. Joining the World Congress of Dermatology from Israel, Canada, Germany, Turkey and Romania, Drs. Ashraf Badawi, Daniel Barolet, Klaus Fritz, Carmen Salavatruz and Meltem Önder, authors of the accepted posters, represent the global success of EndyMed’s 3DEEP® devices.
In addition to the four posters that discuss the successful results of EndyMed’s 3DEEP® technology, EndyMed is also participating in the WCD exhibition in booth #637, where they will be showcasing their Endymed Pro and Endymed Pure professional 3DEEP® RF devices with live demonstrations during the program breaks, as well as their at-home consumer device, the NEWA, which utilizes the same revolutionary RF technology.
About the Accepted Posters
“Effective and Safe Treatment of Atrophic Acne Scars with the Multisource Radiofrequency Treatment Platform: Non Ablative, Fractional Skin Resurfacing and Micro-Needle RF”, by Dr. Ashraf Badawi, MD, PhD., Assistant Professor of Dermatology, Cairo University, Egypt Szeged University, Hungary, Lakeshore Woods Laser Center, Oakville, Canada; “Clinical and Histological Evaluation of Microneedle Radiofrequency Treatment Platform with Fractionated Pulse Mode and Smooth Insertion Motor”, by Dr. Yoram Harth, Board Certified Dermatologist, Medical OR Center, Herzlya Pituach, Israel; “Clinical Evaluation of Radiofrequency Non-Insulated Microneedle Application for Atrophic Acne Scars, Rhytides and Stretch Marks”, by Daniel Barolet MD FRCPC, Montréal, Canada; “Micro-Needle Radiofrequency Remodeling for Acne Scars, Stretch Marks, Wrinkles and Deep Dermal Lesions”, by Klaus Fritz, Dermatology and Laser Centers, Landau, Germany, Carmen Salavatru, University Carol Davila Bukarest, Romania, Meltem Önder, Gazi University Medical Faculty, Ankara-Turkey.
About EndyMed Medical Ltd.
Endymed Medical, established in 2007, is a pioneering global aesthetic device company with a comprehensive product portfolio in non-invasive skin rejuvenation and a global distribution footprint. The FDA approved 3DEEP® RF technology enables physicians and beauty specialists to provide cutting-edge treatment solutions for non-ablative wrinkle reduction, skin tightening, fractional skin resurfacing and RF micro-needling for both the face and body, body contouring and acne scar treatment. Endymed is also leading the way in the design, development and distribution of advanced at-home anti-aging systems, using the company's clinically proven technologies to enable consumers to achieve professional-like results in an at-home setting. The company markets, services and supports its products in 35 countries and has offices in Israel, North America and distributors worldwide. To learn more visit http://www.endymed.com, or call us at +972-4-630-9100.